Ceryx Medical secures £575k seed funding to advance its bioelectronic heart failure therapy.

Ceryx Medical has secured £575k in a seed funding round led by the Development Bank of Wales, alongside backing from angel investors and Parkwalk. The capital will allow the bioelectronics firm to expand its management and technology teams, establish quality systems, and run proof of clinical benefit studies ahead of planned human trials in 2023.

The financing also qualifies Ceryx for an additional £150k grant from Innovate UK through its Regional Angel Investment Accelerator programme. The company is developing novel bioelectronic devices that mimic central pattern generators to restore impaired bodily functions, with an initial focus on creating the first curative cardiac pacemaker for heart failure.